ArticleMembranes2023

Lipid Metabolism Reprogramming and Trastuzumab Resistance in Breast Cancer Cell Lines Overexpressing the ERBB2 Membrane Receptor.

Katia Cortese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.